(1)
Atopic Dermatitis: Severity and Control Assessment During the COVID-19 Pandemic, and Determination of Cardiovascular Risk in Adults. Rev Alerg Mex 2023, 69 (2), 72-77. https://doi.org/10.29262/ram.v69i2.1067.